-
Mashup Score: 0Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study - 7 month(s) ago
Key Points. DMF treatment shows good efficacy in treatment of patients with CTCL, especially for Sézary syndrome with high tumor load.The tolerability of DMF in
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0T-cell lymphoma highlights at ASH 2022: Unmet needs, clinical trial updates & future outlooks - 1 year(s) ago
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Emerging strategies in peripheral T-cell lymphoma - 2 year(s) ago
Abstract. Peripheral T-cell lymphomas (PTCLs) are a heterogenous group of aggressive non-Hodgkin lymphomas that are less chemosensitive than their B-cell counte
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice - 2 year(s) ago
PURPOSE Peripheral T-cell lymphoma (PTCL) includes heterogeneous clinicopathologic entities with numerous diagnostic and treatment challenges. We previously defined robust transcriptomic signatures that distinguish common PTCL entities and identified two novel biologic and prognostic PTCL-not otherwise specified subtypes (PTCL-TBX21 and PTCL-GATA3). We aimed to consolidate a gene expression–based…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home - 2 year(s) ago
It is our pleasure to welcome you to the 14th Annual T-Cell Lymphoma Forum. Presented in a hybrid format for 2022, you will have the option of attending live in La Jolla, CA, or virtually with the conference being live streamed. Our exceptional faculty will present clinically relevant…
Source: events.medscapelive.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Home - 2 year(s) ago
It is our pleasure to welcome you to the 14th Annual T-Cell Lymphoma Forum. Presented in a hybrid format for 2022, you will have the option of attending live in La Jolla, CA, or virtually with the conference being live streamed. Our exceptional faculty will present clinically relevant…
Source: events.medscapelive.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Home - 2 year(s) ago
It is our pleasure to welcome you to the 14th Annual T-Cell Lymphoma Forum. Presented in a hybrid format for 2022, you will have the option of attending live in La Jolla, CA, or virtually with the conference being live streamed. Our exceptional faculty will present clinically relevant…
Source: events.medscapelive.orgCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 10Susan Thornton - 2 year(s) ago
Chief Executive Officer Staff since 2011
Source: Cutaneous Lymphoma FoundationCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Home - 3 year(s) ago
LETTER FROM THE CHAIR Dear Colleagues: It is our pleasure to welcome you to this virtual conference, the 13th Annual T-Cell Lymphoma Forum. This important innovative experience will take you on a unique learning journey, which begins when you enter the Virtual Conference Center. The comprehensive agenda includes the most relevant topics that…
Source: na.eventscloud.comCategories: Dermatology, Latest HeadlinesTweet
#DimethylFumarate treatment in relapsed and refractory cutaneous #TcellLymphoma: a multicenter phase 2 study 👉https://t.co/8WMJs6uSGx @BloodJournal @HeidelbergU🇩🇪 https://t.co/g8SpOZThZF